Search Results - "Vrettou, Charikleia S"

Refine Results
  1. 1

    Endotheliopathy in Acute COVID-19 and Long COVID by Vassiliou, Alice G, Vrettou, Charikleia S, Keskinidou, Chrysi, Dimopoulou, Ioanna, Kotanidou, Anastasia, Orfanos, Stylianos E

    “…The pulmonary endothelium is a highly regulated organ that performs a wide range of functions under physiological and pathological conditions. Since…”
    Get full text
    Journal Article
  2. 2

    Post-Intensive Care Syndrome in Survivors from Critical Illness including COVID-19 Patients: A Narrative Review by Vrettou, Charikleia S, Mantziou, Vassiliki, Vassiliou, Alice G, Orfanos, Stylianos E, Kotanidou, Anastasia, Dimopoulou, Ioanna

    Published in Life (Basel, Switzerland) (12-01-2022)
    “…Current achievements in medical science and technological advancements in intensive care medicine have allowed better support of critically ill patients in…”
    Get full text
    Journal Article
  3. 3

    Pulmonary Embolism in Critically Ill Patients-Prevention, Diagnosis, and Management by Vrettou, Charikleia S, Dima, Effrosyni, Sigala, Ioanna

    Published in Diagnostics (Basel) (03-10-2024)
    “…Critically ill patients in the intensive care unit (ICU) are often immobilized and on mechanical ventilation, placing them at increased risk for thromboembolic…”
    Get full text
    Journal Article
  4. 4
  5. 5

    Changes in Cortisol Secretion and Corticosteroid Receptors in COVID-19 and Non COVID-19 Critically Ill Patients with Sepsis/Septic Shock and Scope for Treatment by Ilias, Ioannis, Vassiliou, Alice G, Keskinidou, Chrysi, Vrettou, Charikleia S, Orfanos, Stylianos, Kotanidou, Anastasia, Dimopoulou, Ioanna

    Published in Biomedicines (23-06-2023)
    “…Sepsis is associated with dysregulated cortisol secretion, leading to abnormal levels of cortisol in the blood. In the early stages of the condition, cortisol…”
    Get full text
    Journal Article
  6. 6
  7. 7
  8. 8

    Comparison of the Mortality Prediction Value of Soluble Urokinase Plasminogen Activator Receptor (suPAR) in COVID-19 and Sepsis by Vassiliou, Alice G, Zacharis, Alexandros, Vrettou, Charikleia S, Keskinidou, Chrysi, Jahaj, Edison, Mastora, Zafeiria, Orfanos, Stylianos E, Dimopoulou, Ioanna, Kotanidou, Anastasia

    Published in Diagnostics (Basel) (18-05-2022)
    “…In the last years, biomarkers of infection, such as the soluble urokinase plasminogen activator receptor (suPAR), have been extensively studied as potential…”
    Get full text
    Journal Article
  9. 9
  10. 10

    Quality of Life, Depression, and Anxiety in Survivors of Critical Illness from a Greek ICU. A Prospective Observational Study by Vrettou, Charikleia S., Mantziou, Vassiliki, Ilias, Ioannis, Vassiliou, Alice G., Orfanos, Stylianos E., Kotanidou, Anastasia, Dimopoulou, Ioanna

    Published in Healthcare (Basel) (05-07-2021)
    “…The physical and psychological consequences of critical illness may affect intensive care unit survivors for up to five years, and hence, health-related…”
    Get full text
    Journal Article
  11. 11
  12. 12

    Clinical Comparison of Post-intensive Care Syndrome and Long Coronavirus Disease by Vrettou, Charikleia S., Jolley, Sarah E., Mantziou, Vassiliki, Dimopoulou, Ioanna

    Published in Critical care clinics (01-01-2025)
    “…Post-intensive care syndrome (PICS) encompasses persistent physical, psychological, and cognitive impairments. The coronavirus disease of 2019 (COVID-19)…”
    Get full text
    Journal Article
  13. 13

    Letter to the Editor for: “Covert Consciousness in Acute Brain Injury Revealed by Automated Pupillometry and Cognitive Paradigms” by Vrettou, Charikleia S., Kominis, Iannis K.

    Published in Neurocritical care (01-08-2024)
    “…[...]the study is subject to various methodological and technical equipment-related limitations, which have also been documented in the field of cognitive…”
    Get full text
    Journal Article
  14. 14
  15. 15
  16. 16

    Effect of Different Early Oxygenation Levels on Clinical Outcomes of Patients Presenting in the Emergency Department With Severe Traumatic Brain Injury by Vrettou, Charikleia S., Giannakoulis, Vassilis G., Gallos, Parisis, Kotanidou, Anastasia, Siempos, Ilias I.

    Published in Annals of emergency medicine (01-03-2023)
    “…Despite the almost universal administration of supplemental oxygen in patients presenting in the emergency department (ED) with severe traumatic brain injury,…”
    Get full text
    Journal Article
  17. 17

    COVID-19-Related ARDS: Key Mechanistic Features and Treatments by Selickman, John, Vrettou, Charikleia S., Mentzelopoulos, Spyros D., Marini, John J.

    Published in Journal of clinical medicine (20-08-2022)
    “…Acute respiratory distress syndrome (ARDS) is a heterogeneous syndrome historically characterized by the presence of severe hypoxemia, high-permeability…”
    Get full text
    Journal Article
  18. 18

    Severe Traumatic Brain Injury and Pulmonary Embolism: Risks, Prevention, Diagnosis and Management by Vrettou, Charikleia S, Dima, Effrosyni, Karela, Nina Rafailia, Sigala, Ioanna, Korfias, Stefanos

    Published in Journal of clinical medicine (02-08-2024)
    “…Severe traumatic brain injury (sTBI) is a silent epidemic, causing approximately 300,000 intensive care unit (ICU) admissions annually, with a 30% mortality…”
    Get full text
    Journal Article
  19. 19

    COMPARATIVE EVALUATION AND PROGNOSTIC UTILITY OF NEURONAL INJURY BIOMARKERS IN COVID-19 PATIENTS: A PROSPECTIVE STUDY by Vrettou, Charikleia S., Vassiliou, Alice G., Pratikaki, Maria, Keskinidou, Chrysi, Tsipilis, Stamatios, Gallos, Parisis, Jahaj, Edison, Orfanos, Stylianos E., Kotanidou, Anastasia, Dimopoulou, Ioanna

    Published in Shock (Augusta, Ga.) (01-12-2022)
    “…Background : COVID-19 disease severity markers include mostly molecules related to not only tissue perfusion, inflammation, and thrombosis, but also biomarkers…”
    Get full text
    Journal Article
  20. 20